Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers (NCT06880861)

🧪 Interventions in This Study

• Non-Interventional Study (OTHER)

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

1. Adults (aged 18+ years)
2. Primary diagnosis of cancer when 15-39 years-old
3. Access to a desktop computer or laptop with reliable internet access
4. No gross motor impairments that prohibit ambulation
5. Willing to complete study requirements
6. English speaking

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

• Mayo Clinic in Arizona — Scottsdale, Arizona

📞 Contact the Study Coordinator

Phone: (480) 574-4052

Email: mailto:ARZENL@mayo.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Hematopoietic and Lymphatic System Neoplasm

• Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies — Seattle, Washington
• Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients — Seattle, Washington
• Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals — Duarte, California
• Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial — Seattle, Washington
• Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer — Portland, Oregon

Explore by condition: All Hematopoietic and Lymphatic System Neoplasm clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.